3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
468
Neoplasms
316
Carcinoma, Non-Small-Cell Lung
269
Prostatic Neoplasms
215
Colorectal Neoplasms
208
Lung Neoplasms
178
Multiple Myeloma
123
Melanoma
110
Carcinoma, Renal Cell
107
Ovarian Neoplasms
94
Carcinoma, Hepatocellular
78
Pancreatic Neoplasms
69
Urinary Bladder Neoplasms
65
Stomach Neoplasms
64
Neoplasm Metastasis
64
Leukemia, Lymphocytic, Chronic, B-Cell
62
Colonic Neoplasms
60
Leukemia, Myeloid, Acute
53
Uterine Cervical Neoplasms
50
Recurrence
49
Liver Neoplasms
46
Lymphoma, Follicular
45
Lymphoma
45
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
39
Esophageal Neoplasms
37
Precursor Cell Lymphoblastic Leukemia-Lymphoma
36
Lymphoma, Large B-Cell, Diffuse
35
Hematologic Neoplasms
35
Head and Neck Neoplasms
35
Lymphoma, Non-Hodgkin
34
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Observational
×
Suicidal Ideation
×
Clear all
NCT03284879
2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
1,086 enrolled